{"id":"W2953229874","doi":"10.1002/hon.95_2629","title":"IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital de l'Enfant-Jésus; Jewish General Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Clinical endpoint; Diffuse large B-cell lymphoma; CHOP; Rituximab; Ven; Oncology; Gastroenterology; Venetoclax; Regimen; Lymphoma; Randomized controlled trial; Chronic lymphocytic leukemia; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008503177,0.0003297645,0.0007053031,0.0001428521,0.0001649918,0.0005446183,0.0002759139,0.0003924505,0.0009378461],"category_scores_gemma":[0.0006269774,0.0001926896,0.00063076,0.0002859734,0.0002642031,0.0003353185,0.000262913,0.0008401489,0.0001852273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003757542,"about_ca_system_score_gemma":0.0003323969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006512869,"about_ca_topic_score_gemma":0.001516811,"domain_scores_codex":[0.9997324,0.0001322703,0.00001480168,0.00005362481,0.00003193231,0.00003499718],"domain_scores_gemma":[0.9996427,0.00006918143,0.000124942,0.00003560768,0.00002080879,0.0001066787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4491875,0.009732042,0.3994803,0.000789247,0.004071545,0.0004877564,0.0003384285,0.002001914,0.02482644,0.0001660079,0.004752862,0.1041661],"study_design_scores_gemma":[0.06321925,0.1433288,0.7817535,0.00007946232,0.002167997,0.0008473952,0.0001661205,0.001457303,0.002351938,0.0001663766,0.004425213,0.00003659147],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99773,0.001355164,0.00006148728,0.00006708816,0.00001590106,0.00006233904,0.0003229338,0.00001164607,0.000373412],"genre_scores_gemma":[0.9978749,0.0004818327,0.0001474907,0.000143366,0.00005123072,0.00005984721,0.000969721,0.000003520309,0.0002680716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009378461,"threshold_uncertainty_score":0.004496992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0226620262075771,"score_gpt":0.3245637619910975,"score_spread":0.3019017357835204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}